Drugs in the Medical Treatment of Cushing's Syndrome – An Update on Mifepristone and Pasireotide

Expert Opinion on Emerging Drugs - United Kingdom
doi 10.1517/14728214.2012.679263
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa Healthcare

Related search

Cushing's Syndrome: Update on Signs, Symptoms and Biochemical Screening

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2015English

Suppression of Medical Conditions by Cushing's Syndrome

BMJ
1995English

Preoperative Medical Treatment in Cushing's Syndrome. Frequency of Use and Its Impact on Postoperative Assessment. Data From ERCUSYN

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2018English

Medical Treatment of Intracranial Atherosclerosis: An Update

Journal of Stroke
NeurologyCardiovascular MedicineCardiology
2017English

The Medical Treatment With Pasireotide in Cushing’s Disease: An Italian Multicentre Experience Based on “Real-World Evidence”

Endocrine
2019English

Uterine Fibroids: An Update on Current and Emerging Medical Treatment Options

Therapeutics and Clinical Risk Management
2019English

An Unusual Presentation of Cushing's Syndrome

Endocrine Abstracts
2018English

Cyclic Cushing's Syndrome: An Overview

Pituitary
EndocrinologyMetabolismDiabetes
2004English

PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy